<DOC>
	<DOCNO>NCT00508534</DOCNO>
	<brief_summary>This study examine effect alter gastric pH healthy volunteer pharmacokinetics SB-751689 without food .</brief_summary>
	<brief_title>A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy adult male female age 21 55 , inclusive , eligible study . Female subject must nonchildbearing potential include premenopausal female document ( medical report verification ) hysterectomy bilateral oophorectomy postmenopausal define 12 month spontaneous amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/ml 6 week postsurgical bilateral oophorectomy without hysterectomy . The subject body mass index ( BMI ) 19 31 kg/m2 BMI= ( weight kg ) / ( height meter ) 2 Subjects must genotyped poor metabolizers heterozygous extensive metabolizers CYP2C19 . The subject capable give informed consent , include compliance requirement restriction list consent form . Genotyped homozygous extensive metabolizers CYP2C19 ( Section 6.1.1 CYP2C19 Polymorphism Genotyping ) . Any clinically relevant abnormality identify screen history physical laboratory examination , 12lead electrocardiogram ( ECG ) and/or 24 hour Holter , include QTc &gt; = 450 msec . Positive urine drug screen screen . Positive urine test alcohol predose . Positive HIV screen Chronic hepatitis B C , evidence positive Hepatitis B surface antigen Hepatitis C antibody . Urinary cotinine level indicative smoking screening . History smoking use nicotine containing product within one year study &gt; 10 packyear history smoke overall . History regular alcohol consumption exceed 7 units/week woman 14 units/week men ( 1 unit = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month screen . History drug abuse within 6 month study . The subject participate clinical trial receive drug new chemical entity 30 day 5 halflives , twice duration biological effect drug ( whichever longer ) prior first dose current study medication . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug include antacid , include vitamin , herbal dietary supplement ( include St. John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer 5 halflives , whichever long ) prior first dose study medication , unless , opinion Investigator Sponsor , medication interfere study procedure compromise subject safety . Consumption red wine , grapefruit , grapefruit juice grapefruitcontaining product within 14 day prior first dose study medication . Donation blood excess 500 mL within 56 day prior dose . Evidence renal , hepatic biliary impairment History serious gastrointestinal disease History sensitivity study medication , component thereof history drug allergy , opinion physician responsible , contraindicate participation . History clinically significant cardiovascular disease . History pernicious anemia , pancreatitis , osteosarcoma kidney stone . Medical condition might alter bone metabolism . Liver function test ( ALT , AST , GGT , alkaline phosphatase , total bilirubin ) and/or parathyroid hormone ( PTH ) test CPK outside reference range screening . Males unwilling refrain father child study 14 day follow last dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>pharmacokinetic study ,</keyword>
	<keyword>gastric pH</keyword>
</DOC>